Linda R. Gowing
Evidence-Based Practice Unit
Drug and Alcohol Services Council
161 Greenhill Road
Parkside
Name/email consistency: high
- Alpha2 adrenergic agonists for the management of opioid withdrawal. Gowing, L., Farrell, M., Ali, R., White, J. Cochrane. Database. Syst. Rev (2004)
- Buprenorphine for the management of opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2004)
- Substitution treatment of injecting opioid users for prevention of HIV infection. Gowing, L., Farrell, M., Bornemann, R., Ali, R. Cochrane. Database. Syst. Rev (2004)
- Alpha2 adrenergic agonists for the management of opioid withdrawal. Gowing, L., Farrell, M., Ali, R., White, J. Cochrane. Database. Syst. Rev (2003)
- Alpha2-adrenergic agonists in opioid withdrawal. Gowing, L.R., Farrell, M., Ali, R.L., White, J.M. Addiction (2002)
- Opioid antagonists with minimal sedation for opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2002)
- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2002)
- Buprenorphine for the management of opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2002)
- Opioid antagonists under sedation or anaesthesia for opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2001)
- Alpha2 adrenergic agonists for the management of opioid withdrawal. Gowing, L., Farrell, M., Ali, R., White, J. Cochrane. Database. Syst. Rev (2001)
- Opioid antagonists and adrenergic agonists for the management of opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2000)
- Buprenorphine for the management of opioid withdrawal. Gowing, L., Ali, R., White, J. Cochrane. Database. Syst. Rev (2000)
- Systematic review processes and the management of opioid withdrawal. Gowing, L.R., Ali, R.L., White, J.M. Aust. N. Z. J. Public. Health (2000)